Teva Pharmaceutical Industries Limited

From Teva Pharmaceutical Industries's results release of 3 november 2026; its quarterly report has since been filed.

• Revenue

  Actual

  US$ 4,4B

  -1,9% y/y ↓
  +6,1% q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  US$ 0,20

  -46% y/y ↓

  Guided

  —

  No guide given

  EPS, adjusted: US$ 0,86

• Operating income, GAAP

  Actual

  US$ 714M

  -19% y/y ↓

  Guided

  —

  No guide given

  Operating income, adjusted: US$ 1,39B

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.